Molecular Mechanisms of Network Pharmacology-Based Immunomodulation of Huangqi (Astragali Radix)

Authors

  • Raymond Rubianto Tjandrawinata Fakultas Bioteknologi, Universitas Katolik Indonesia Atma Jaya ,
  • Anindini Winda Amalia Pengobatan Tradisional Tiongkok/Fakultas Kesehatan Institut Ilmu Kesehatan Bhakti Wiyata ,
  • Hartati Tuna Pengobatan Tradisional Tiongkok/Fakultas Kesehatan Institut Ilmu Kesehatan Bhakti Wiyata ,
  • Viedya Novalinda Said Pengobatan Tradisional Tiongkok/Fakultas Kesehatan Institut Ilmu Kesehatan Bhakti Wiyata ,
  • Santi Tan Dexa Laboratories of Biomolecular Sceinces, Dexa Group ,

DOI:

https://doi.org/10.35814/jifi.v20i2.1301

Keywords:

Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.) Hsiao, Huangqi, immunomodulation, network pharmacology

Abstract

Astragali Radix (Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.) Hsiao, also known as Huangqi) has been used to improve stamina and immunity for thousands of years. However, the bioactive components and their mechanisms are still unclear, limiting its clinical application. In this research, for the first time, network pharmacology was used to investigate the molecular mechanisms of Huangqi and its bioactive components that play an important role in improving the immune system. An amount of 1,430 immunomodulation-related target proteins was collected from the human genome database, with 171 target proteins from 20 bioactive components, and resulted in 60 intersection target proteins. Subsequently, the networks of common target and protein-protein interaction (PPI) were analyzed. The results showed that Huangqi influenced the modulations of lymphocytes (B cells and T cells), natural killer cells, macrophages, cytokines, immunoglobulins, and immune signal transduction. To a certain limit, this study revealed the potential bioactive components and pharmacological mechanisms of Huangqi in immunomodulation. It was able to direct novel drug development for treating immune system deficiency.

References

Downloads

Published

2022-10-30

Issue

Vol. 20 No. 2 (2022): JIFI

Section

Articles

License

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.